Insulin Resistance Clinical Trial
Official title:
Effectiveness of Cinnamon on Insulin Resistance and Corporate Composition of Obese Schoolchildren
Childhood obesity is one of the most serious public health problems of the 21st century. It is considered that if there are no changes in prevention and treatment strategies there will be an increase to 70 million obese children by 2025. Of the only pharmacological treatments accepted at this age to improve insulin resistance is metformin, but it can condition gastrointestinal, muscular and hepatic adverse events. Cinnamon is an alternative therapy, which due to its high concentrations of polyphenols, improves insulin resistance by decreasing the proinflammatory environment that occurs in this group of patients, and unlike metformin with less frequent adverse events. The effectiveness of cinnamon has been demonstrated by decreasing insulin resistance in the adult population.
Controlled clinical trial, 100 children aged 10 to 15 years with obesity Body Mass Index
(BMI> 2 SD) will be selected. Children and parents who agree to participate will be measured
anthropometry (weight, height, BMI, body fat) and Tanner stage. Once the 100 children have
been selected and registered, a determination will be made after 8 hours of fasting leptin,
ghrelin, insulin, lipid profile, liver function tests, creatinine and cinnamic acid.
Subsequently they will be randomly assigned to a group that receives the intervention with
cinnamon 3000mg / day, or placebo; Both groups will receive diet and physical activity
recommendations according to the World Health Organization (WHO) guidelines. They will be
followed for 16 weeks. During this period, patients will be contacted weekly to confirm the
consumption of the capsules and interrogation of adverse effects such as dyspepsia,
gastrointestinal disturbances and headache. They will be scheduled monthly for capsule
counting and interrogation of adverse effects. At the end of the 16-week follow-up,
anthropometry, fasting after 8 hours of leptin, ghrelin, insulin lipid profile, liver
function tests, creatinine and cinnamic acid will be performed.
Statistical analysis: Shapiro Wilk test will be applied to the variables with quantitative
measurement scale to identify the type of distribution; in the case of parametric
distribution, the data with averages and standard deviation will be presented, in case of
presenting non-parametric distribution, medium and minimum and maximum values will be used.
In the case of qualitative variables, they will be expressed with percentages and simple
frequencies. Baseline characteristics will be compared between the two groups with t-Student
or U-Mann Whitney according to the type of distribution of the variables. To evaluate the
effect of the intervention, body fat deltas and biochemical measurements will be calculated
by subtracting the final value (after 16 weeks of intervention) from the initial (baseline)
value and statistical significance will be evaluated using comparisons between groups with
paired t- or Wilcoxon. Covariance analysis control of confounding variables (ANCOVA) will be
carried out.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03142633 -
MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
|
||
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05354245 -
Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)
|
N/A | |
Completed |
NCT03383822 -
Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
Completed |
NCT04203238 -
Potato Research for Enhancing Metabolic Outcomes
|
N/A | |
Recruiting |
NCT03658564 -
Preoperative Oral Carbohydrate Treatment Minimizes Insulin Resistance
|
N/A | |
Completed |
NCT04183257 -
Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
|
Phase 4 | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT03627104 -
Effect of Dietary Protein and Energy Restriction in the Improvement of Insulin Resistance in Subjects With Obesity
|
N/A | |
Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A | |
Active, not recruiting |
NCT03288025 -
Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE)
|
N/A | |
Completed |
NCT03809182 -
Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.
|
Phase 4 | |
Completed |
NCT01809288 -
Identifying Risk for Diabetes and Heart Disease in Women
|
||
Completed |
NCT04642482 -
Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity
|
Phase 4 | |
Terminated |
NCT03278236 -
Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men?
|
N/A | |
Not yet recruiting |
NCT06159543 -
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
|
N/A | |
Withdrawn |
NCT04741204 -
Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer
|
Phase 4 | |
Not yet recruiting |
NCT05540249 -
Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG
|
N/A |